Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2008
11/20/2008WO2008138943A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
11/20/2008WO2008138558A1 Axomadol for treating pain from arthritis
11/20/2008WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases
11/20/2008WO2008138131A1 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/20/2008WO2008092591A3 Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent
11/20/2008WO2008078157A3 Bioengineered intervertebral discs and methods for their preparation
11/20/2008WO2008027812A3 Imidazopyridine and imidazopyrimidine derivatives
11/20/2008WO2007129019A8 Sulfonamide compounds useful as edg receptor modulators
11/20/2008WO2004087055A3 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
11/20/2008US20080287528 Therapeutic methods and compositions involving isoflavones
11/20/2008US20080287521 Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1)
11/20/2008US20080287509 Pharmaceutical Composition for the Treatment of Bone Fracture
11/20/2008US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/20/2008US20080287496 1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels
11/20/2008US20080287477 Novel Compounds as Modulators of Ppar
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287458 Dihydroquinone and dihydronaphthridine inhibitors of JNK
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287446 Sulfonyl Containing Compounds as Cysteine Protease Inhibitors
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287400 Comprising risedronate, a chelating agent, and, means for effecting delayed release of the risedronate and the chelating agent in the small intestine; enteric coating
11/20/2008US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene
11/20/2008US20080287349 Fibroblast growth factor 20 and methods of use thereof
11/20/2008US20080286335 Enhancement Of The Calcium Sensing Receptor
11/20/2008US20080286329 Blood-derived plastic bone tissue articles; Young's Modulus of 0.03 GPa to 50 GPa; article; biological response modifiers hormones, growth factors, cytokines, extracellular matrix molecules; crosslinking agents iridoid derivatives, diimidates, diones; plasticizers phthalate, adipate, plant oils, glycols
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286265 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators
11/20/2008CA2687001A1 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/20/2008CA2686895A1 Synthetic peptide materials for joint reconstruction, repair and cushioning
11/20/2008CA2685379A1 Axomadol for treating pain from arthritis
11/19/2008EP1992641A2 GLP-1 analogues
11/19/2008EP1992636A2 Process for correction of a disulfide misfold in Fc molecules
11/19/2008EP1992348A1 Pharmaceutical combination
11/19/2008EP1991548A1 Salt of cd 80 antagonist
11/19/2008EP1991539A1 New salts of an indole derivative and their use in medicine
11/19/2008EP1991538A1 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
11/19/2008EP1991274A1 Method of treatment, prophylaxis and diagnosis of pathologies of the bone
11/19/2008EP1751131B1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
11/19/2008EP1680413B1 NEW RAR-beta RECEPTOR-ACTIVATING LIGAND, METHOD FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS
11/19/2008EP1677806B1 Methods for treating acute and overuse sprain and strain using hyaluronic acid
11/19/2008EP1537108B1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
11/19/2008EP1453539B1 Immunotherapeutic methods and systems
11/19/2008EP1448545B1 Nf-kb inhibitors
11/19/2008EP1377667B1 Fusion proteins for specific treatment of cancer and auto-immune diseases
11/19/2008EP1268775B1 The high bone mass gene of 11q13.3
11/19/2008CN101309918A [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
11/19/2008CN101309678A Medicament for use in connection with cartilage impairment
11/19/2008CN101309598A High-potency sweetener composition with calcium and compositions sweetened therewith
11/19/2008CN101307345A Method for preparing ebosin
11/19/2008CN101307105A Human parathyroid hormone 1-34 peptide analogue capable of expressing in series and being released by synchronousacid hydrolysis, preparation method thereof and use
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN101306193A Use of neuritis auxin in preparing wound healing medicine
11/19/2008CN101306176A Traditional Chinese medicine paste, its preparation method and use
11/19/2008CN101306170A Traditional Chinese medicinal preparation for fracture setting
11/19/2008CN101306151A Traditional Chinese drug composition for treating injuries from falls
11/19/2008CN101306122A Medicaments for treating lumbar intervertebral disc
11/19/2008CN101306112A Baimaiyutong paster
11/19/2008CN101306073A Formulation for treating rheumatism arthralgia syndrome
11/19/2008CN101306007A Use of Yibosu in preparing medicine for treating rheumatoid arthritis
11/19/2008CN101306003A Use of cyaniding 3-0 glucoside in preparing medicament or food for preventing and curing atrophic arthritis
11/19/2008CN101305989A Yibosu capsule and its preparation method
11/19/2008CN101305988A Compound alendronate sodium vitamine D3 orally disintegrating tablets and preparation method thereof
11/19/2008CN101305978A Preparation method and use of bee brood freeze-dry powder
11/19/2008CN101305777A Gingko pulp paste
11/19/2008CN100434436C NO donor-type hydrocortisone derivative, its preparing method and antiphlogistic use
11/19/2008CN100434103C Chinese medicine composition for treating anemogenous-ache disease
11/19/2008CN100434101C Chinese patent medicine for treating protrasion of lumbar intervertebral disc
11/19/2008CN100434084C Pharmaceutical composition for treating rheumatic and rheumatoid diseases and its preparation process
11/19/2008CN100434069C Stable compositions of atorvastatin prepared with wet granulation
11/18/2008US7452976 Immunoglobulin specific to kinase insert domain-containing receptor (KDR) for use in treatment and prevention of inflammation, psoriasis, rheumatoid arthritis and tumor growth; immunotherapy
11/18/2008US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
11/18/2008US7452907 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452898 Use of 1-O-octadecylpropanediol-3-cidofovir to treat viral diseases such as HIV, influenza, herpes virus, cytomegalovirus, hepatitis virus, Epstein-Barr virus, varicella zoster virus, orthopox virus, ebola virus and papilloma virus
11/18/2008US7452890 Substituted pyrazoles
11/18/2008US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides
11/18/2008US7452884 Methods for inhibiting angiogenesis
11/18/2008US7452880 p38 kinase inhibitors; arthritis, Crohn's disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease; pyrazolo(3,4-d)pyrimidines
11/18/2008US7452879 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/18/2008US7452873 Inhibitors of GSK-3 and uses thereof
11/18/2008US7452535 Methods of treatment using CTLA-4 antibodies
11/18/2008CA2440222C Triazolopyridines as anti-inflammatory agents
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2381219C Monomeric protein of the tgf-beta family
11/18/2008CA2375743C Methods and compositions for the support, regeneration and repair of connective tissues
11/18/2008CA2362281C Combinations for the treatment of diseases involving angiogenesis
11/18/2008CA2339190C Compressed compositions comprising clarified xanthan gum
11/18/2008CA2201855C Preventive or remedy for diseases caused by abnormalities in cartilage tissues
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/13/2008WO2008136733A1 Method and means for culturing osteoblastic cells
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008135984A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level
11/13/2008WO2008135734A1 Novel antibody and use in diagnosis and therapy of arthropathies
11/13/2008WO2008135661A2 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008WO2008135153A1 Novel polymorphic form of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methyl-sulfonyl)phenyl]-3(2h)-pyridazinone (fhmp)
11/13/2008WO2008135152A1 Novel amorphous forms of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methyl-sulfonyl)phenyl]-3(2h)-pyridazinone (fhmp)
11/13/2008WO2008118454A3 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
11/13/2008WO2008083678A3 Pharmaceutically active compounds
11/13/2008WO2008081331A3 Enhancing the level of antibody expression by framework re-engineering
1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 820